TARS Smart Money
Tarsus Pharmaceuticals, Inc.
1W: -3.5%
1M: -11.8%
3M: +8.9%
YTD: -9.6%
1Y: +27.3%
3Y: +362.3%
5Y: +220.5%
$73.00
-2.46 (-3.26%)
Weekly Expected Move ±7.1%
$63
$68
$73
$78
$83
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026294
Institutions Holding
+9 vs prior
95.0%
Ownership
-5.19%
42
New
103
Increased
117
Reduced
32
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | LINK WILLIAM J PHD | director | S-Sale | 759 | $79.00 | $60K | Filing |
| 2026-09-15 | LINK WILLIAM J PHD | director | S-Sale | 11,675 | $78.33 | $915K | Filing |
| 2026-09-15 | LINK WILLIAM J PHD | director | S-Sale | 66 | $80.01 | $5K | Filing |
| 2026-09-04 | Azamian Bobak R. | officer: president/ceo and board chair | S-Sale | 7,100 | $90.27 | $641K | Filing |
| 2026-09-04 | Lin Elizabeth Yeu | officer: chief medical officer | S-Sale | 1,590 | $90.00 | $143K | Filing |
| 2026-09-04 | Lin Elizabeth Yeu | officer: chief medical officer | S-Sale | 5,386 | $90.00 | $485K | Filing |
| 2026-09-04 | Lin Elizabeth Yeu | officer: chief medical officer | S-Sale | 5,387 | $85.00 | $458K | Filing |
| 2026-09-04 | Azamian Bobak R. | officer: president/ceo and board chair | S-Sale | 2,900 | $91.27 | $265K | Filing |
| 2026-09-04 | Neervannan Seshadri | officer: chief operating officer | S-Sale | 4,564 | $85.00 | $388K | Filing |
| 2026-09-02 | Lin Elizabeth Yeu | officer: chief medical officer | S-Sale | 1,590 | $80.00 | $127K | Filing |
| 2026-09-02 | Lin Elizabeth Yeu | officer: chief medical officer | S-Sale | 5,387 | $80.00 | $431K | Filing |
| 2026-09-02 | Azamian Bobak R. | officer: president/ceo and board chair | S-Sale | 10,000 | $80.06 | $801K | Filing |
| 2026-09-01 | Lin Elizabeth Yeu | officer: chief medical officer | S-Sale | 4,601 | $73.86 | $340K | Filing |
| 2026-06-17 | Azamian Bobak R. | officer: president/ceo and board chair | S-Sale | 4,582 | $61.24 | $281K | Filing |
| 2026-06-17 | Azamian Bobak R. | officer: president/ceo and board chair | S-Sale | 5,418 | $61.81 | $335K | Filing |
| 2026-06-16 | Farrow Jeffrey S | officer: see remarks | S-Sale | 14,396 | $60.95 | $877K | Filing |
| 2026-06-15 | LINK WILLIAM J PHD | director | S-Sale | 1,928 | $62.94 | $121K | Filing |
| 2026-06-15 | LINK WILLIAM J PHD | director | S-Sale | 10,572 | $61.97 | $655K | Filing |
| 2026-06-15 | Goodrich Katherine | director | S-Sale | 2,954 | $62.08 | $183K | Filing |
| 2026-03-20 | Neervannan Seshadri | officer: chief operating officer | S-Sale | 2,989 | $66.75 | $200K | Filing |
| 2026-03-19 | Neervannan Seshadri | officer: chief operating officer | S-Sale | 4,589 | $67.00 | $307K | Filing |
| 2026-03-19 | Lin Elizabeth Yeu | officer: chief medical officer | S-Sale | 390 | $67.00 | $26K | Filing |
| 2026-03-19 | Mottiwala Aziz | officer: chief commercial officer | S-Sale | 4,440 | $67.00 | $297K | Filing |
| 2026-03-19 | Wahl Bryan | officer: general counsel | S-Sale | 4,231 | $67.00 | $283K | Filing |
| 2026-03-19 | Whitfield Dianne C. | officer: chief human resources officer | S-Sale | 4,174 | $67.00 | $280K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 3,856,137 | $243M | +303,525 | 2026-06-30 | Filing |
| Deep Track Capital, LP | 3,666,768 | $231M | +66,768 | 2026-06-30 | Filing |
| RTW INVESTMENTS, LP | 3,357,059 | $211M | +11,034 | 2026-06-30 | Filing |
| Jupiter Topco LLC | 2,808,796 | $177M | +2,808,796 | 2026-06-30 | Filing |
| Paradigm Biocapital Advisors LP | 2,775,649 | $175M | +213,495 | 2026-06-30 | Filing |
| MORGAN STANLEY | 1,827,082 | $115M | -117,190 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,793,064 | $113M | +32,523 | 2026-06-30 | Filing |
| JENNISON ASSOCIATES LLC | 1,663,655 | $105M | -48,469 | 2026-06-30 | Filing |
| TANG CAPITAL MANAGEMENT LLC | 1,568,266 | $99M | +379,642 | 2026-06-30 | Filing |
| MILLENNIUM MANAGEMENT LLC | 1,427,124 | $90M | +862,545 | 2026-06-30 | Filing |
| BANK OF AMERICA CORP /DE | 1,193,182 | $75M | -1,195 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 1,105,689 | $70M | -15,402 | 2026-06-30 | Filing |
| STATE STREET CORP | 1,072,951 | $68M | +94,739 | 2026-06-30 | Filing |
| Vestal Point Capital, LP | 1,050,000 | $66M | +850,000 | 2026-06-30 | Filing |
| Assenagon Asset Management S.A. | 947,495 | $60M | -332,699 | 2026-06-30 | Filing |
| Invesco Ltd. | 785,808 | $49M | +43,311 | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 742,693 | $47M | +303,067 | 2026-06-30 | Filing |
| Frazier Life Sciences Management, L.P. | 728,644 | $46M | — | 2026-06-30 | Filing |
| D. E. Shaw & Co., Inc. | 710,559 | $45M | -80,587 | 2026-06-30 | Filing |
| FMR LLC | 672,949 | $42M | -60,385 | 2026-06-30 | Filing |